Multimodality Imaging for the Staging of Pancreatic Cancer. Surg Oncol Clin N Am 2021 Oct;30(4):621-637
Date
09/14/2021Pubmed ID
34511186DOI
10.1016/j.soc.2021.06.006Scopus ID
2-s2.0-85111014021 (requires institutional sign-in at Scopus site) 5 CitationsAbstract
Imaging plays a key role in the diagnosis, staging, and follow-up of pancreatic ductal adenocarcinoma. The pancreatic protocol dual-phase multidetector computed tomography scan is the imaging modality of choice. A computed tomography scan is highly accurate for pancreatic tumor detection, assessment of resectability, and detection of metastatic disease. This article reviews key principles of the acquisition, interpretation, and reporting of pancreatic ductal adenocarcinoma imaging with computed tomography scanning and highlights potential roles for newer and supplemental imaging technologies. We discuss the importance of structured interpretation and reporting for providing the most complete and accurate assessment of tumor stage and resectability.
Author List
McKinney M, Griffin MO, Tolat PPAuthors
Michael O. Griffin MD, PhD Associate Professor in the Radiology department at Medical College of WisconsinParag P. Tolat MD Chief, Associate Professor in the Radiology department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Carcinoma, Pancreatic DuctalHumans
Multimodal Imaging
Neoplasm Staging
Pancreatic Neoplasms
Tomography, X-Ray Computed
